Walleye Trading
SVA

Walleye Trading’s Sinovac Biotech, Ltd SVA Stock Holding History

Walleye Trading’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-49,065
Closed -$346 – 4901
2017
Q3 		$346 Buy
49,065
+962
+2% +$6.57K ﹤0.01% 2797
2017
Q2 		$325 Buy
+48,103
New +$264K ﹤0.01% 2748
2016
Q3 		– Sell
-3,800
Closed -$23K – 6057
2016
Q2 		$23K Sell
3,800
-10,200
-73% -$62.5K ﹤0.01% 4490
2016
Q1 		$89K Buy
14,000
+13,100
+1,456% +$78.7K ﹤0.01% 3449
2015
Q4 		$5K Sell
900
-7,600
-89% -$40.9K ﹤0.01% 4955
2015
Q3 		$43K Buy
8,500
+8,100
+2,025% +$42.9K ﹤0.01% 3615
2015
Q2 		$2K Buy
+400
New +$2.11K ﹤0.01% 4707

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Walleye Trading's SVA Position: Q4 2017 in Review

Walleye Trading sold out of Sinovac Biotech, Ltd (SVA) in Q4 2017, closing a stake of 49,065 shares — an estimated $346 sold.

Walleye Trading first reported a position in SVA in Q2 2015 and held it in 7 quarters. The position peaked at $89K in Q1 2016. 31 funds tracked by Wall St. Rank hold SVA as of Q4 2017.

  • Walleye Trading reported no remaining Sinovac Biotech, Ltd position as of Q4 2017 after selling out during the quarter.
  • Walleye Trading sold 49,065 Sinovac Biotech, Ltd shares in Q4 2017, an estimated $346.
  • Walleye Trading first reported a position in Sinovac Biotech, Ltd in Q2 2015 and held it in 7 quarters.
  • Walleye Trading's Sinovac Biotech, Ltd position peaked at $89K in Q1 2016.
  • 31 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2017.

Based on Walleye Trading's 13F filing for Q4 2017, filed 14 Feb 2018.